Emeis (WBO:ORP2) Other Current Receivables: €274 Mil (As of Dec. 2025)


WBO:ORP2 Emeis WBO:ORP2
46 GF Score
Price €13.98
GF Value €9.21
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Emeis Other Current Receivables?

Emeis WBO:ORP2 -0.99% 46 Other Current Receivables is €274 Mil as of Dec. 2025. GuruFocus rates WBO:ORP2 with a GF Score™ of 46/100 and a GF Value™ of €9.21 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Emeis's Other Current Receivables for the quarter that ended in Dec. 2025 was €274 Mil.

Emeis's quarterly Other Current Receivables declined from Dec. 2024 (€230.63 Mil) to Jun. 2025 (€188.26 Mil) but then increased from Jun. 2025 (€188.26 Mil) to Dec. 2025 (€274.36 Mil).

Emeis's annual Other Current Receivables declined from Dec. 2023 (€330.89 Mil) to Dec. 2024 (€230.63 Mil) but then increased from Dec. 2024 (€230.63 Mil) to Dec. 2025 (€274.36 Mil).

Emeis Other Current Receivables Related Terms

Emeis Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Emeis's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emeis Other Current Receivables Chart

Emeis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 860.85 365.04 330.89 230.63 274.36

Emeis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 330.89 186.84 230.63 188.26 274.36
WBO:ORP2
46GF Score
Emeis WBO:ORP2
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emeis Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €274 Mil mean?
Emeis (WBO:ORP2) has a Other Current Receivables of €274 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Emeis and its competitors.
Is Emeis' Other Current Receivables too high?
Emeis' current Other Current Receivables is €274 Mil. Overall, Emeis has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emeis' Other Current Receivables compare to HCA and THC?
Emeis' Other Current Receivables of €274 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Emeis and its competitors. Emeis's current Other Current Receivables is €274 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Based on GuruFocus' analysis, Emeis (WBO:ORP2) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.21, compared to a current price of €13.98 — trading 51.8% above its estimated fair value. The current Other Current Receivables is €274 Mil. Emeis' overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Emeis (WBO:ORP2), the current Other Current Receivables is €274 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Emeis (WBO:ORP2) Overvalued in 2026?

Based on GuruFocus' analysis, Emeis stock appears to be overvalued. The current stock price of €13.98 is trading 51.8% above its estimated GF Value™ of €9.21. GuruFocus considers Emeis to be Significantly Overvalued.

Key valuation signals for WBO:ORP2:

  • Other Current Receivables: €274 Mil
  • GF Value™: €9.21 vs. price of €13.98 (51.8% above fair value)
  • GF Score™: 46/100 with 8 warning signs

No single metric tells the full story. See the WBO:ORP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Emeis Business Description

Address 12, Rue Jean Jaures, CS 10032, Puteaux Cedex, Paris, FRA, 92 813
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
46GF Score

Get the complete analysis for WBO:ORP2

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.98
Price
€9.21
GF Value